Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.

Trial Details

NCT ID
NCT06144762
Phase
NA
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Biological/Vaccine: Blood sample and tissue sample
Locations (sample)
  • Montpellier, France|43.61093,3.87635

Key Eligibility Criteria

  • Patient aged \>18 2.
  • Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy.
  • Negative pregnancy test for women of childbearing potential
  • Patients affiliated to a social protection system

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →